Another notable buy includes CRISPR Therapeutics AG (NASDAQ: CRSP ), with ARKK ETF purchasing 31,983 shares, reflecting a continued investment in the gene-editing company with a total dollar value of ...

Palantir shares closed at a record high Wednesday for the second consecutive day, as a cooling of global trade tensions has ...

Shares in Palantir Technologies hit a new all-time high on Wednesday as the tech-heavy Nasdaq composite also gained. But Palantir stock pulled back in midday trading.On the stock market today, ...

Key Points Tarrifs, President Trump’s visit to Saudi Arabia and global uncertainty has had a huge impact on tech stocks this ...

Live Updates Live Coverage Updates appear automatically as they are published. Saudi Tech Deals 9:55 am by Gerelyn Terzo Bank ...

The three stocks in this analysis continue to look very strong, and as a result, it looks as if tech companies are going to continue to see a lot of inflows, as the risk appetite continues to increase ...

We recently published a list of the 13 Best High Volume Stocks to Buy Now. In this article, we are going to take a look at ...

U.S. stock futures edge higher, Nvidia stock continues to climb after surging yesterday on an AI deal with a Saudi firm, and ...

Palantir was a little-known stock trading at just $8. Today, it's a $250 billion juggernaut at the heart of AI, defense, and ...

What comes next for Palantir stock is pain for shareholders. The stock may not fall, but it certainly will not go up by 1,000% like it has over the last five years. The stock is plain overvalued even ...

The stock is clearly overvalued at today's prices. 2025 has been one of the most manic-depressive stock markets in history.

Nabeel Qureshi said Palantir screened for three particular types of people very carefully.